EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Insulin Sensitivity and Associated Plasma Proteomics During Sex Hormone Therapy

Sarah A van Eeghen iD, Laura Pyle iD, Phoom Narongkiatikhun iD, Ye Ji Choi iD, Taryn G Vosters iD, Irene G M van Valkengoed iD, Petter Bjornstad iD, Sarah E Siegelaar iD, Natalie J Nokoff iD, Martin den Heijer iD, Daniël H van Raalte iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf573 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Sarah A van Eeghen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center of Expertise on Gender Dysphoria, Department of Internal Medicine, Amsterdam UMC, location Vrije Universiteit, 1081 HV Amsterdam, The Netherla…. Hauptthemen laut MEDLINE: Insulin Resistance, Testosterone, Estradiol, Proteome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Diabetes Foundation, Dutch Kidney Foundation, Dutch Kidney Foundation Collaboration Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Women are generally protected against insulin resistance and related comorbidities when compared with men, potentially due to the role of sex hormones. While epidemiological and animal studies suggest that sex hormones may impact insulin sensitivity, studies in humans on the effects of estradiol and testosterone treatment on insulin sensitivity assessed by gold-standard measures remain limited. The molecular mechanisms involved are also not well understood. Therefore, we aimed to investigate changes in insulin sensitivity and associated change in plasma proteome following 3 months of sex hormone therapy.

Methods

This prospective, observational study included 29 individuals initiating feminizing (estradiol with GnRH analogue; n = 16) or masculinizing (testosterone; n = 13) therapy. Measurements at baseline and after 3 months included insulin sensitivity, assessed via hyperinsulinemic-euglycemic clamp (M-value: adjusted for lean body mass and M/I ratio: M-value adjusted for plasma insulin concentrations), along with plasma proteomics.

Results

During feminizing hormone therapy, insulin sensitivity increased (M-value: + 23.3%, M/I ratio: + 20.2%; P < .05), whereas during masculinizing hormone therapy, no changes were observed. Of the differentially expressed plasma proteins (49 during feminizing and 356 during masculinizing hormone therapy), 16 correlated with changes in insulin sensitivity. Several were involved in immunoregulation and inflammation (vascular endothelial growth factor D, 5′-nucleotidase), iron homeostasis and erythropoiesis (hepcidin, transferrin receptor protein 1:cytoplasmic domain), and oxidative stress (superoxide dismutase 3).

Conclusion

Feminizing hormone therapy, characterized by high serum estradiol and low serum testosterone concentrations, enhanced insulin sensitivity. These findings highlight the impact of sex hormones on insulin sensitivity and may inform sex-specific precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceTestosteroneEstradiolProteomeBlood ProteinsHumansFemaleMaleAdultProteomicsMiddle AgedProspective StudiesGlucose Clamp Technique

Stichwörter der Autor:innen

estradiolinsulin sensitivityplasma proteomicssex hormone therapysex hormonestestosterone

Substanzen

TestosteroneEstradiolProteomeBlood Proteins

Autor:innen und Institutionen

  • Center of Expertise on Gender Dysphoria, Department of Internal Medicine, Amsterdam UMC, location Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.
  • Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Department of Endocrinology and Metabolism, Amsterdam UMC, location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, University of Washington School of Medicine, Seattle, WA 98195, USA.
  • Department of Pediatrics, Section of Endocrinology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
  • Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.

ORCID-Profile: Sarah A van Eeghen, Laura Pyle, Phoom Narongkiatikhun, Ye Ji Choi, Taryn G Vosters, Irene G M van Valkengoed, Petter Bjornstad, Sarah E Siegelaar, Natalie J Nokoff, Martin den Heijer, Daniël H van Raalte

Förderung

  • Dutch Diabetes Foundation
  • Dutch Kidney Foundation
  • Dutch Kidney Foundation Collaboration Grant
  • MenoPause consortium
  • NWA-ORC
  • Dutch Research Council

Zitieren

APA

van Eeghen, S. A., Pyle, L., Narongkiatikhun, P., Choi, Y. J., Vosters, T. G., van Valkengoed, I. G. M., Bjornstad, P., Siegelaar, S. E., Nokoff, N. J., den Heijer, M., & van Raalte, D. H. (2025). Insulin Sensitivity and Associated Plasma Proteomics During Sex Hormone Therapy. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf573

Vancouver

van Eeghen SA, Pyle L, Narongkiatikhun P, Choi YJ, Vosters TG, van Valkengoed IGM, et al. Insulin Sensitivity and Associated Plasma Proteomics During Sex Hormone Therapy. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf573

BibTeX
@article{vanEeghen2025,
  author = {van Eeghen, Sarah A and Pyle, Laura and Narongkiatikhun, Phoom and Choi, Ye Ji and Vosters, Taryn G and van Valkengoed, Irene G M and Bjornstad, Petter and Siegelaar, Sarah E and Nokoff, Natalie J and den Heijer, Martin and van Raalte, Daniël H},
  title = {Insulin Sensitivity and Associated Plasma Proteomics During Sex Hormone Therapy},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf573}
}
Kostenlos starten →